CMA
WST icon

Cedar Mountain Advisors’s West Pharmaceutical WST Stock Holding History

Cedar Mountain Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.26K Hold
23
– – ﹤0.01% 543
2026
Q1 		$5.76K Buy
23
+13
+130% +$3.23K ﹤0.01% 608
2025
Q4 		$2.75K Hold
10
– – ﹤0.01% 371
2025
Q3 		$2.62K Buy
+10
New +$2.43K ﹤0.01% 393

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GWI
Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
BZWA
Blue Zone Wealth Advisors Los Angeles, California $573M AUM 22.86% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Cedar Mountain Advisors's WST Position: Q2 2026 in Review

Cedar Mountain Advisors held its West Pharmaceutical (WST) position steady in Q2 2026 at 23 shares worth $8.26K. The position accounts for ﹤0.01% of the portfolio, ranked #543.

Cedar Mountain Advisors first reported a position in WST in Q3 2025 and has held it in 4 quarters since. 120 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Cedar Mountain Advisors held 23 shares of West Pharmaceutical worth $8.26K as of Q2 2026.
  • Cedar Mountain Advisors left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #543 holding.
  • Cedar Mountain Advisors first reported a position in West Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • 120 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.